Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-018-0487-4
Abstract: Novel molecular markers that address the heterogeneity of breast cancer (BC) and provide meaningful prognostic information for BC patients are needed. Kallikrein-related peptidase 6 (KLK6) is aberrantly expressed and functionally implicated in BC and, like… read more here.
Keywords: klk6 expression; outcome; breast cancer; klk6 ... See more keywords